Hydrogen sulfide reduced renal tissue fibrosis by regulating autophagy in diabetic rats

Lin Li1, Ting Xiao1, Fang Li1

  • 1Department of Cardiology, The First Affiliated Hospital of South China University, Hengyang, Hunan 421001, P.R. China.

Insights

Hydrogen sulfide (H2S) treatment improved renal tissue fibrosis in diabetic rats by modulating key molecular pathways. This study highlights H2S as a potential therapeutic agent for diabetic nephropathy.

Area of Science:

  • Nephrology
  • Endocrinology
  • Biochemistry

Background:

  • Diabetic nephropathy is a major complication of diabetes mellitus, characterized by renal tissue fibrosis.
  • Hydrogen sulfide (H2S) has shown potential protective effects in various disease models.

Purpose of the Study:

  • To investigate the therapeutic effect of hydrogen sulfide (H2S) on renal tissue fibrosis in streptozotocin (STZ)-induced diabetic rats.
  • To elucidate the underlying mechanisms of H2S action in diabetic nephropathy.

Main Methods:

  • Diabetic rat model induced by STZ injection.
  • Treatment groups included control, STZ, STZ + H2S, and H2S alone.
  • Assessment of renal fibrosis markers (Masson's trichrome, collagen IV, PAS staining).
  • Western blot analysis for MMP9, MMP7, TIMP1, SOD, AKT, TGF-β1, NF-κB, and autophagy proteins.

Main Results:

  • STZ-induced diabetes caused significant renal fibrosis, increased collagen IV and PAS staining, and elevated proteinuria.
  • Diabetic rats showed increased expression of MMP9, MMP7, TIMP1, autophagy proteins, AKT, TGF-β1, and NF-κB, with decreased SOD.
  • H2S treatment ameliorated renal fibrosis, reduced proteinuria, decreased collagen IV and PAS staining.
  • H2S treatment normalized the expression of MMPs, TIMP1, autophagy proteins, AKT, TGF-β1, NF-κB, and increased SOD levels.

Conclusions:

  • Hydrogen sulfide (H2S) demonstrates a protective effect against renal tissue fibrosis in diabetic rats.
  • H2S may exert its renoprotective effects by inhibiting autophagy, upregulating superoxide dismutase (SOD), and downregulating AKT, transforming growth factor-β1 (TGF-β1), and nuclear factor-κB (NF-κB).
  • H2S represents a promising therapeutic strategy for managing diabetic nephropathy.

Related Concept Videos